Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Tuberculosis Medicine & Life Sciences
Mycobacterium tuberculosis Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
HIV Medicine & Life Sciences
Pulmonary Tuberculosis Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
tuberculosis Agriculture & Biology
Sputum Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1998 2017

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials

Savic, R. M., Weiner, M., Mackenzie, W. R., Engle, M., Whitworth, W. C., Johnson, J. L., Nsubuga, P., Nahid, P., Nguyen, N. V., Peloquin, C. A., Dooley, K. E. & Dorman, S. E. 2017 (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Research - peer-reviewArticle

rifapentine
Phase II Clinical Trials
Pulmonary Tuberculosis
Therapeutics
Pharmacokinetics

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance

Manson, A. L. , Cohen, K. A. , Abeel, T. , Desjardins, C. A. , Armstrong, D. T. , Barry, C. E. , Brand, J. , Chapman, S. B. , Cho, S. N. , Gabrielian, A. , Gomez, J. , Jodals, A. M. , Joloba, M. , Jureen, P. , Lee, J. S. , Malinga, L. , Maiga, M. , Nordenberg, D. , Noroc, E. , Romancenco, E. & 27 others Salazar, A., Ssengooba, W., Velayati, A. A., Winglee, K., Zalutskaya, A., Via, L. E., Cassell, G. H., Dorman, S. E., Ellner, J., Farnia, P., Galagan, J. E., Rosenthal, A., Crudu, V., Homorodean, D., Hsueh, P. R., Narayanan, S., Pym, A. S., Skrahina, A., Swaminathan, S., van der Walt, M., Alland, D., Bishai, W. R., Cohen, T., Hoffner, S., Birren, B. W., Earl, A. M. & TBResist Global Genome Consortium Jan 16 2017 (Accepted/In press) In : Nature Genetics.

Research output: Research - peer-reviewArticle

Multidrug-Resistant Tuberculosis
Multiple Drug Resistance
Mycobacterium tuberculosis
Mutation
Molecular Pathology

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N. C., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. L. & Lamichhane, G. Aug 1 2017 In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152

Research output: Research - peer-reviewArticle

biapenem
Rifampin
Mycobacterium tuberculosis
Pharmaceutical Preparations
In Vitro Techniques

Reply to alffenaar et al

Peloquin, C. A., Dorman, S. E., Vernon, A., Migliori, G. B. & Nahid, P. 2017 In : Clinical Infectious Diseases. 64, 1, p. 105-106 2 p.

Research output: Research - peer-reviewLetter

Serologic Responses in Childhood Pulmonary Tuberculosis

Nonyane, B. A. S., Nicol, M. P., Andreas, N. J., Rimmele, S., Schneiderhan-Marra, N., Workman, L. J., Perkins, M. D., Joos, T., Broger, T., Ellner, J. J., Alland, D., Kampmann, B., Dorman, S. E. & Zar, H. J. Jul 15 2017 (Accepted/In press) In : Pediatric Infectious Disease Journal.

Research output: Research - peer-reviewArticle

Pulmonary Tuberculosis
Tuberculosis
Antigens
Area Under Curve
Immunoglobulin G